---
name: Robert Green
last: Green
image: /get2013/images/Robert-Green.jpg
---

Robert C. Green, MD, MPH is a medical geneticist and a clinical researcher who directs the G2P research program (genomes2people.org) in translational genomics and health outcomes in the Division of Genetics at Brigham and Women’s Hospital and Harvard Medical School. Dr. Green is principal investigator of the NIH-funded REVEAL Study involving randomized clinical trials to disclose a genetic risk factor for Alzheimer’s disease. He also co-directs the NIH-funded PGen Study, the first prospective study of direct-to-consumer genetic testing services and leads the MedSeq Project, the first NIH-funded research study to explore the use of whole genome sequencing in the clinical practice of medicine. Dr. Green is currently Associate Director for Research of the Partners Center for Personalized Genetic Medicine, and a Board Member of the Council for Responsible Genetics. He co-chairs the ACMG Working Group that is developing recommendations for management of incidental findings in clinical sequencing.

